CLIA: 39D2085645
New York State has a separate and unique regulatory approval process for laboratory diagnostic testing. PeriRx is currently in the application process with our SaliMark™ OSCC test and is vigorously committed to pursuing this application approval.
Monthly Archives: February 2012
Prevalidation of Salivary Biomarkers for Oral Cancer Detection
By David Elashoff, Hui Zhou, Jean Reiss, Jianghua Wang, Hua Xiao, Bradley Henson, Shen Hu,Martha Arellano, Uttam Sinha, Anh Le, Diana Messadi, Marilene Wang, Vishad Nabili, Mark Lingen, Darly Morris, Timothy Randolph, Ziding Feng, David Akin, Dragana A. Kastratovic, David Chia, Elliot Abemayor, and David T.W. Wong\
Cancer Epidemiology, Biomarkers & Prevention
Prevalidation of Salivary Biomarkers for Oral Cancer Detection
David Elashoff, Hui Zhou, Jean Reiss, et al.
Cancer Epidemiol Biomarkers Prev 2012;21:664-672. Published OnlineFirst February 1, 2012.